Postbiotics

Can dead lactic acid bacteria catch up to living lactic acid bacteria?

Since lactic acid bacteria are dead, are postbiotics still helpful for the gut? Are they safer and more effective than probiotics? This is a question that almost anyone choosing gut health ingredients these days encounters at least once.

To answer briefly, it means that rather than using the general term "dead bacteria," one must look at the specific strain, the inactivation method, and the clinical results of the preparation itself. Safety or efficacy cannot be guaranteed by name alone.

---

Context of the Question: The Common Belief that Lactic Acid Bacteria Must Be Alive

For a long time, it was believed that lactic acid bacteria must be alive to reach the gut. However, postbiotics are not alive. They are created by inactivating microorganisms through methods such as heat treatment or crushing, and then forming the cells or cell components into a preparation. In this regard, they are clearly different from probiotics. Probiotics refer to living microorganisms, prebiotics to the food for microorganisms, and synbiotics to a combination of the two. Postbiotics belong to yet another category.

The interesting point here is that the assumption that inactivated microorganisms will have no effect is not always correct. A distinction must be made between metabolites where the cell itself has disappeared and inactivated cell preparations where cell components remain. The ISAPP definition views the latter, preparations of inactivated microorganisms and their components with proven health benefits, as postbiotics. Therefore, while the term "dead lactic acid bacteria" is not technically wrong, what is contained within them is more important.

---

Identity of the Ingredient: The Boundaries Defined by ISAPP

The 2021 ISAPP consensus defined postbiotics as preparations of inactivated microorganisms and/or their components that confer a health benefit on the host. Two conditions are attached to this definition: first, they must be in an inactive state, and second, the health benefit must be proven. A product cannot be called a postbiotic if it meets only one of these two conditions.

The reason this definition is important is that many things commercially called "dead bacteria" may not fall into this category. For example, pure metabolites without cells are not postbiotics. Similarly, preparations that have been inactivated but whose health effects have not been verified are also excluded. This means that just because they share the same name does not mean they are the same ingredient.

---

Reasons for Expectation: The Advantage of Non-proliferation

Expectations for postbiotics stem from the characteristic of inactivation. Since they are not living bacteria, they do not proliferate in the gut. This means they have high storage stability and can be candidates for consideration instead of probiotics in certain environments. However, this advantage does not immediately mean they are "more effective for everyone" or "unconditionally safe." The fact that they do not proliferate is simply a difference in mechanism, not a guarantee of superior efficacy.

Even with the same original strain, the function of the final preparation can vary depending on the heat treatment method or the degree of crushing. Therefore, it is risky to switch products based solely on the category name. Just because a heat-treated preparation of strain A showed a certain effect, there is no guarantee that a crushed preparation of strain B, or even a preparation of the same strain A made with a different process, will produce the same result.

---

Differences in Product Form: The Core is the Original Strain and Inactivation Method

Postbiotics can ultimately be made in various forms, such as powders, capsules, or infant formula additives. However, before checking the form, one should verify the name of the original strain, the inactivation method, and the components. Comparison is only possible when these three elements are indicated.

For example, the clinical trials to refer to will differ depending on whether the product is chosen for gut health, irritable bowel syndrome, diarrhea, or atopic dermatitis. However, many products only emphasize the category name "postbiotics" without disclosing the specific original strain, process, or target symptoms. In such cases, one must first determine whether the product meets the ISAPP definition or is simply a general ingredient containing inactivated bacterial cells.

---

When Taken with Other Biotics

There is an increasing number of cases where probiotics, prebiotics, synbiotics, and postbiotics are taken together. Theoretically, they may act through different mechanisms, but there is still insufficient evidence to generalize that this combination is better for specific individuals. In particular, infants, pregnant women, immunocompromised individuals, and those with severe diseases must first check the safety data for the preparation and the target group.

It is also necessary to check whether other biotics are being taken and what medications or supplements are currently in use. The fact that postbiotics are inactive does not automatically eliminate ingredient allergies, contamination, or manufacturing quality issues. Inactivation only stops the life activities of the microorganism; it does not guarantee the safety of the entire product.

---

Individual circumstances and safety signals

Even with inactive preparations, caution is required in certain situations. For infants, pregnancy, immunocompromised states, or severe diseases, checking the safety data for the preparation and the target group is the priority. Furthermore, since ingredient allergies or manufacturing quality issues are not eliminated, one should be mindful of adverse reactions when taking them for the first time.

You must seek medical attention immediately if you experience bloody stools, fever, dehydration, weight loss, or severe allergic symptoms. This criterion applies not only to postbiotics but to any new gut health supplement. Being 'inactive' does not mean the risk is zero; it is important to develop the habit of checking if there is data that matches your specific health condition.

---

The Gap Between Human Evidence and Expectations

While clinical research on postbiotics is increasing, it is not yet as definitive as expected. A 2024 literature analysis pointed out that since the ISAPP consensus, there has been a disproportionate number of reviews compared to original studies, indicating a need for more clinical trials. In other words, while there are many conceptual definitions and candidate ingredients, direct verification in humans is relatively scarce.

A 2026 meta-analysis on irritable bowel syndrome showed signs of improvement in 1,062 participants across 4 trials. However, there was significant heterogeneity and the certainty of evidence was low. An analysis of pediatric atopic dermatitis also showed signs of low certainty for specific strains, which could not be generalized to other strains. A review of 12 trials for healthy infant formula showed no difference from the control group in terms of growth, gastrointestinal symptoms, allergies, or infections.

Rather than concluding that these results mean "there is no effect," it is more appropriate to understand them as "there are currently limited signals in specific formulations and specific target groups." We must acknowledge that a significant gap still exists between expectations and evidence.

---

What are the differences between ingredients with similar names?

Postbiotics are often compared to probiotics, prebiotics, and synbiotics. These are distinct categories with different mechanisms. Furthermore, within postbiotics, inactive microbial cells must be distinguished from cell-free metabolites. These differences are easily blurred when they are given similar names or grouped into the same family.

Storage stability is not the same as clinical efficacy. The fact that a product can be stored for a long time in powder form does not mean it is effective for the desired symptoms. Similarly, just because a family's mechanism is theoretically sound does not mean the results of human trials for a specific formulation support it. Name, stability, and efficacy are each different axes.

---

Criteria to Check Today

So, what should you look for? First, check if the original strain, inactivation method, and dosage are indicated. Next, determine whether the purpose is general gut health, irritable bowel syndrome, diarrhea, or atopic dermatitis, and check if there are trials for that specific product. Also, check if you are an infant, pregnant, immunocompromised, or taking other biotics concurrently.

Rather than relying on the term "dead lactobacillus," a realistic standard for choosing this ingredient is to verify the original strain, inactivation method, composition, dosage, and target symptoms, and to avoid applying the results of one formulation to the entire category.

References

1. ISAPP consensus definition of postbiotics.
2. ISAPP consensus paper.
3. Postbiotics: Mapping the Trend.
4. Postbiotics for IBS: meta-analysis.
5. ESPGHAN review of postbiotic infant formula.

---

This text explains the origin of the raw materials, the scope of research, and precautions before consumption. As this cannot replace individual diagnosis or treatment, please consult a medical professional if you are taking medication or if symptoms persist. If sudden and severe symptoms such as difficulty breathing or decreased consciousness occur after consumption, seek help from 119 or the emergency room.